Dr. Gao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Brigham and Women's HospitalResidency, Internal Medicine, 2012 - 2015
Harvard Medical SchoolClass of 2012
Certifications & Licensure
MA State Medical License 2012 - 2026
NH State Medical License 2024 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2021 May 21
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Jul 22
Roles: Principal Investigator
- NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Start of enrollment: 2022 Mar 29
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 342 citationsPhysiologic Medium Rewires Cellular Metabolism and Reveals Uric Acid as an Endogenous Inhibitor of UMP SynthaseJason R. Cantor, Monther Abu-Remaileh, Naama Kanarek, Elizaveta Freinkman, Xin Gao
Cell. 2017-04-06 - 79 citationsEvaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma.Praful Ravi, Charlene Mantia, Christopher Su, Karl Sorenson, Dean Elhag
JAMA Oncology. 2020-10-01 - 18 citationsNCCN Guidelines® Insights: Prostate Cancer, Version 3.2024.Edward M Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Rhonda Bitting
Journal of the National Comprehensive Cancer Network. 2024-04-01
Journal Articles
- Combination Immunotherapy and Targeted Therapy: Will New Combinations Raise the Tail of the Survival Curve?Gao X, Kidney Cancer Journal, 10/7/2018
Press Mentions
Enzalutamide Survival Benefit in Metastatic Prostate Cancer Persists Beyond Five YearsJune 20th, 2022- Diving Deeper into Benefit of Avelumab Maintenance in Bladder CancerJune 24th, 2021
Weymouth Kidney Cancer Victim’s Memory Fuels MGH Research FundraiserNovember 13th, 2019
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
